Selective cell loss in Edinger-Westphal in asymptomatic elders and Alzheimer's patients

Neurobiology of Aging

Volumn 22, Issue 5, 2001, Pages 729-736

  Scinto, L F M ^a,d   Frosch, M ^b,d   Wu, C K ^c   Daffner, K R ^a,d   Gedi, N ^c   Geula, C ^c,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer disease; Edinger Westphal nucleus; Immunohistochemistry; Neuronal loss; Pupillary reflex; Stereology; Tangles

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BRAIN NUCLEUS; CELL LOSS; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; EDINGER WESTPHAL NUCLEUS; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCEPHALON; NEUROPATHOLOGY; OCULOMOTOR NERVE; PRIORITY JOURNAL; PUPIL; PUPIL REFLEX;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; CELL COUNT; HUMANS; MESENCEPHALON; NEUROFIBRILLARY TANGLES; NEURONS; OCULOMOTOR NERVE; PHOSPHORYLATION; REFLEX, PUPILLARY; TAU PROTEINS;

EID: 0035160073     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(01)00235-4     Document Type: Article

References (45)

1. Pupil dilation assay by tropicamide is modulated by apolipoprotein Eε 4 allele dosage in Alzheimer's disease
2. Neuropathological staging of Alzheimer-related changes
3. Pupil reactivity in AD: A reappraisal
4. Cholinergic sensitivity of the pupil of demented Parkinson's disease patients
5. Is videopupillography useful in the diagnosis of Alzheimer's disease?
6. Response of the pupil to tropicamide is not a reliable test for Alzheimer's disease
7. The pupillary response to tropicamide in Alzheimer's disease
8. The Edinger-Westphal nucleus: Sources of input influencing accommodation, pupilloconstriction, and choroidal flow
9. Pupil response to tropicamide in Alzheimer's disease and other neurodegenerative disorders
10. Tropicamide eye drops cannot be used for reliable diagnosis of Alzheimer's disease
11. The Oregon Brain Aging Study: Neuropathology accompanying healthy aging in the oldest old
12. Pupillary dilation to tropicamide is not specific for Alzheimer's disease
13. Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones, in memory of William R. Thompson
14. Evaluation of tropicamide in the diagnosis of early Alzheimer's disease
15. Pupillary response to tropicamide in Japanese patients with alcoholic dementia, Alzheimer's disease, and vascular dementia
16. Alzheimer's disease: Cell-specific pathology isolates the hippocampal formation
17. Pupil dilation response to the acetylcholine receptor antagonist tropicamide in normal aged and senile dementia subjects
18. Increased mydriatic response to tropicamide is a sign of cholinergic hypersensitivity but not specific to late-onset sporadic type of Alzheimer's disease
19. Enhanced miotic response to topical dilute pilocarpine in patients with Alzheimer's disease
20. The peripheral and central projections of the Edinger-Westphal nucleus in the rat. A light and electron microscopic study
21. Hypersensitivity in the pupil dilation response to a cholinergic antagonist in patients with Alzheimer's disease and Down's syndrome
22. Transneuronal retinal input to the primate Edinger-Westphal nucleus
23. Pupil dilation response to tropicamide: A biological test for Alzheimer's disease
24. Pupil dilation by tropicamide in Alzheimer's disease patients and probands
25. Can tropicamide eye drop response differentiate patients with progressive supranuclear palsy and Alzheimer's disease from healthy control subjects?
26. Reevaluation of the efferent projections of the Edinger-Westphal nucleus in the cat
27. Pupillary response to tropicamide in patients with Alzheimer's disease
28. The prolyl isomerase Pin 1 restores the function of Alzheimer-associated phosphorylated tau protein
29. Detecting Alzheimer's disease
30. Apolipoprotein Eε4 allele, and pupillary response to tropicamide in Alzheimer's disease, and cognitively normal subjects
31. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
32. Very mild Alzheimer's disease: Informant-based clinical, psychometric, and pathologic distinction from normal aging
33. Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease
34. Alzheimer's disease, and computerized pupillography
35. The mydriatic effect of tropicamide and its diagnostic use in Alzheimer's disease
36. Experiencia con el test pupilar de tropicamida en la enfermedad de alzheimer
37. Anticholinergic eye drops in differentiating Alzheimer's disease and depression
38. A potential noninvasive neurobiological test for Alzheimer's disease
39. Focal pathology in the Edinger-Westphal nucleus explains pupillary hypersensitivity in Alzheimer's disease
40. Pupillary changes following microinjections of opioids, sympathomimetics and cholinomimetics into the oculomotor nucleus in the dog
41. Consensus report of the working group on: "Molecular and biochemical markers of Alzheimer's disease"
42. Diagnosis of Alzheimer's disease by using the tropicamide test
43. Pupillary response to topical tropicamide as a marker for Alzheimer's disease
44. Detection of Alzheimer's disease with eyeblink classical conditioning and the pupil dilation response